Curaleaf Holdings, Inc. (OTCMKTS:CURLF – Free Report) – Research analysts at Alliance Global Partners upped their FY2024 EPS estimates for shares of Curaleaf in a note issued to investors on Thursday, November 7th. Alliance Global Partners analyst A. Grey now forecasts that the company will post earnings of ($0.26) per share for the year, up from their previous forecast of ($0.27). The consensus estimate for Curaleaf’s current full-year earnings is ($0.24) per share. Alliance Global Partners also issued estimates for Curaleaf’s Q4 2024 earnings at ($0.08) EPS, Q1 2025 earnings at ($0.07) EPS, Q2 2025 earnings at ($0.06) EPS, Q3 2025 earnings at ($0.06) EPS, Q4 2025 earnings at ($0.06) EPS and FY2025 earnings at ($0.25) EPS.
Several other research analysts have also commented on the company. Needham & Company LLC reissued a “buy” rating and issued a $6.25 price objective on shares of Curaleaf in a research report on Thursday, August 8th. Cormark downgraded Curaleaf from a “moderate buy” rating to a “hold” rating in a report on Thursday.
Curaleaf Price Performance
Shares of Curaleaf stock opened at $2.13 on Monday. The stock has a market capitalization of $1.38 billion, a P/E ratio of -7.34 and a beta of 0.86. The company has a current ratio of 1.09, a quick ratio of 0.50 and a debt-to-equity ratio of 0.83. The business’s fifty day moving average price is $2.97 and its 200 day moving average price is $3.79. Curaleaf has a twelve month low of $2.07 and a twelve month high of $6.40.
About Curaleaf
Curaleaf Holdings, Inc operates a cannabis operator in the United States. It operates through two segments, Domestic Operations and International Operations. The company offers flower, pre-rolls, flower pots, and dry-herb vaporizer cartridges; concentrates for vaporizing which includes pre-filled vaporizer cartridges and disposable vaporizer pens; and concentrates for dabbing, such as mints, distillate droppers, mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles.
Featured Articles
- Five stocks we like better than Curaleaf
- How to Use the MarketBeat Dividend Calculator
- California Resources Stock Could Be a Huge Long-Term Winner
- Comparing and Trading High PE Ratio Stocks
- Observability Wars: Datadog and Dynatrace Vie for Data Dominance
- Manufacturing Stocks Investing
- Airbnb Stock Attracts Attention With Strong Cash Flow Strategy
Receive News & Ratings for Curaleaf Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Curaleaf and related companies with MarketBeat.com's FREE daily email newsletter.
